Adaptive Optics Retinal Imaging
ConditionGlaucoma, Primary Open Angle
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorFood and Drug Administration (FDA)
About this trial
The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical use of AO technology.
Eligibility criteria
Qualifiers
Are 21 years of age or older.
Have the ability to cooperate with instructions during adaptive optics imaging (similar to instructions given during a clinical eye exam).
Have the ability to understand and sign an informed consent.
Have been diagnosed with POAG (cohort 2).
Disqualifiers
Are under 21 years of age.
Have a condition which prevents adequate images from being obtained (e.g. unstable fixation or media opacity).
Have visual correction outside of the range +4 diopters (D) to -8 D.
Have a history of adverse reaction to mydriatic drops.
Trial design
Treatments tested in this trial
- oxygen inhalation
- Adaptive optics imaging
Treatment groups
150 Participants
are divided into 5 treatment groupsSponsors and collaborators
Food and Drug Administration (FDA)
Lead sponsor
University of Maryland, Baltimore
Collaborator
Source ClinicalTrials.gov